Patents by Inventor Florence Smadja

Florence Smadja has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI CD44 ANTIBODIES FOR ERADICATING LEUKAEMIC STEM CELLS AND BREAST CANCER STEM CELLS
    Publication number: 20100040540
    Abstract: The present invention provides the use of an anti-CD44 antibody, a (Fab?)2, Fab, Fab? fragment thereof, an IgG or IgM isotype thereof, in a method for eradicating pathological stem cells in cancer therapy, and more specifically in breast cancer and leukaemia therapy.
    Type: Application
    Filed: March 19, 2009
    Publication date: February 18, 2010
    Applicants: Institut National De La Sante et De La Recherche Medicale (INSERM), University Health Network
    Inventors: Florence Smadja, John Dick
  • Chimeric Anti Cd44 Antibodies and Their Use for Treating Acute Myeloid Leukemia
    Publication number: 20070237761
    Abstract: The present invention provides the use of an anti-CD44 antibody, a (Fab?)2, Fab, Fab? fragment thereof, an IgG or IgM isotype thereof, in the preparation of a medicament for eradicating pathological stem cells in cancer therapy, and more specifically in acute myeloid leukaemia therapy.
    Type: Application
    Filed: November 19, 2004
    Publication date: October 11, 2007
    Applicants: Institut National de la Sante et de la Recherche M, University Health Network
    Inventors: Florence Smadja, John Dick, Jean Kadouche
  • Anti CD44 antibodies for eradicating stem cells
    Publication number: 20070184051
    Abstract: The present invention provides the use of an anti-CD44 antibody, a (Fab?)2, Fab, Fab? fragment thereof, an IgG or IgM isotype thereof, in the preparation of a medicament for eradicating pathological stem cells in cancer therapy, and more specifically in acute myeloid leukaemia therapy.
    Type: Application
    Filed: November 28, 2006
    Publication date: August 9, 2007
    Applicants: Institut National De La Sante et De La Recherche Medicale (INSERM), University Health Network
    Inventors: Florence Smadja, John Dick
  • Anti CD44 antibodies for eradicating stem cells
    Publication number: 20050147606
    Abstract: The present invention provides the use of an anti-CD44 antibody, a (Fab?)2, Fab, Fab? fragment thereof, an IgG or IgM isotype thereof, in the preparation of a medicament for eradicating pathological stem cells in cancer therapy, and more specifically in acute myeloid leukaemia therapy.
    Type: Application
    Filed: October 8, 2004
    Publication date: July 7, 2005
    Inventors: Florence Smadja, John Dick
  • Methods for regulating hematopoietic cell differentiation with polymers containing disaccharide units
    Publication number: 20040204384
    Abstract: The invention concerns the use of a polymer comprising an efficient amount of
    Type: Application
    Filed: May 4, 2004
    Publication date: October 14, 2004
    Applicant: Institut National De La Sante Et De La Recherche Medial (Inserm)
    Inventors: Florence Smadja-Joffe, Rachida-Sihem Charrad, Christine Chomienne, Bertrand Delpech, Claude Jasmin
  • Means for regulating hematopoietic differentiation
    Publication number: 20030032621
    Abstract: The invention concerns the use of a polymer comprising an efficient amount of disaccharide units each consisting of a molecule with N-acetyl-D-glucosamine structure bound by the O-glucoside &bgr;1,4 linkage to a molecule with glucuronic acid structure for producing a medicine designed to induce or stimulate the differentiation of hematopoietic cells, and leukemic cells in particular.
    Type: Application
    Filed: August 13, 2001
    Publication date: February 13, 2003
    Inventors: Florence Smadja-Joffe, Rachida-Sihem Charrad, Christine Chomienne, Bertrand Delpech, Claude Jasmin